Outlook Therapeutics, Inc. (41ON)
Market Closed
17 Jul, 20:00
XSTU 
€
1. 22
-0.04
-3.4019%
€
- Market Cap
- P/E Ratio
- Div Yield
11,600 Volume
-0.23 Eps
€ 1.26
Previous Close Want to track 41ON and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
41ON Earnings Reports FAQ
What is the earnings per share (EPS) for 41ON?
The current EPS is -0.23.
What is the company's earnings growth rate?
Outlook Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Outlook Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Outlook Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 41ON at this time, as Outlook Therapeutics, Inc has no recent EPS data to calculate it.
